Thermo Fisher Scientific, Inc. Share Price
Equities
TMO
US8835561023
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 568.21 USD | -0.80% |
|
-2.89% | +9.22% |
| 12-08 | Why the Fed's Next Move Matters More Than Markets Admit |  |
| 12-08 | Analyst recommendations: 3M Company, Exxon Mobil, Mastercard, Netflix, Tesla… | |
| Capitalization | 213B 184B 173B 160B 296B 19,246B 322B 2,010B 778B 9,087B 801B 784B 33,291B | P/E ratio 2025 * |
31.8x | P/E ratio 2026 * | 28.7x |
|---|---|---|---|---|---|
| Enterprise value | 241B 208B 195B 181B 334B 21,762B 365B 2,273B 880B 10,275B 906B 887B 37,644B | EV / Sales 2025 * |
5.45x | EV / Sales 2026 * | 5.1x |
| Free-Float |
86.06% | Yield 2025 * |
0.29% | Yield 2026 * | 0.31% |
Last Transcript: Thermo Fisher Scientific, Inc.
| 1 day | -0.34% | ||
| 1 week | -2.89% | ||
| Current month | -3.83% | ||
| 1 month | -0.73% | ||
| 3 months | +16.52% | ||
| 6 months | +41.38% | ||
| Current year | +9.22% |
| 1 week | 560.16 |  | 588.11 |
| 1 month | 556.46 | | 602.32 |
| Current year | 385.46 | | 610.97 |
| 1 year | 385.46 | | 610.97 |
| 3 years | 385.46 | | 627.88 |
| 5 years | 385.46 | | 672.34 |
| 10 years | 119.75 | | 672.34 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 57 | 14/10/2009 |
| Director of Finance/CFO | 58 | 31/07/2015 | |
Sebastian Pacios
CTO | Chief Tech/Sci/R&D Officer | - | 30/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Scott Sperling
BRD | Director/Board Member | 67 | 08/11/2006 |
Marc Casper
CHM | Chairman | 57 | 25/02/2020 |
Tyler Jacks
BRD | Director/Board Member | 64 | 25/05/2009 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 7.43% | 26 M€ | +11.55% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.80% | -2.89% | +7.34% | +0.05% | 213B | |
| -1.47% | -0.08% | +2.99% | +108.40% | 201B | |
| -0.78% | +0.15% | -2.45% | -17.42% | 159B | |
| -3.77% | -7.10% | +4.19% | +102.59% | 139B | |
| -0.30% | +1.62% | -17.19% | -13.25% | 56.15B | |
| -2.17% | -1.11% | +17.88% | +16.34% | 48.93B | |
| -2.10% | -5.10% | +1.32% | -8.86% | 40.32B | |
| -2.77% | +4.86% | +2.28% | - | 37.85B | |
| -2.54% | +0.67% | +3.57% | +12.38% | 36.44B | |
| -1.16% | -0.78% | -23.88% | -36.29% | 34.22B | |
| Average | -1.45% | -0.90% | -0.39% | +18.22% | 96.6B | |
| Weighted average by Cap. | -0.91% | -1.60% | +1.79% | +34.70% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 44.26B 38.1B 35.76B 33.25B 61.28B 3,990B 66.86B 417B 161B 1,884B 166B 163B 6,902B | 46.5B 40.03B 37.58B 34.93B 64.39B 4,192B 70.25B 438B 170B 1,979B 175B 171B 7,252B |
| Net income | 6.71B 5.77B 5.42B 5.04B 9.29B 605B 10.13B 63.16B 24.46B 285B 25.17B 24.63B 1,046B | 7.38B 6.36B 5.97B 5.55B 10.22B 666B 11.15B 69.54B 26.93B 314B 27.71B 27.12B 1,152B |
| Net Debt | 27.91B 24.03B 22.56B 20.97B 38.65B 2,516B 42.16B 263B 102B 1,188B 105B 103B 4,353B | 23.68B 20.38B 19.14B 17.79B 32.79B 2,135B 35.77B 223B 86.35B 1,008B 88.88B 86.98B 3,693B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/12/25 | 568.21 $ | -0.80% | 1,412,168 |
| 05/12/25 | 572.77 $ | -0.43% | 1,873,706 |
| 04/12/25 | 575.24 $ | -0.90% | 1,961,858 |
| 03/12/25 | 580.45 $ | +0.01% | 1,186,616 |
| 02/12/25 | 580.37 $ | -0.82% | 1,918,180 |
Delayed Quote Nyse, December 08, 2025 at 09:00 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- TMO Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition